(Q46946875)

26 December 2017

title

Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas (English)

1 reference

26 December 2017

1 reference

Fumihiro Shoji

1

1 reference

26 December 2017

Ichiro Yoshino

2

1 reference

26 December 2017

Tokujiro Yano

3

1 reference

26 December 2017

Takuro Kometani

4

1 reference

26 December 2017

Taro Ohba

5

1 reference

26 December 2017

Hidenori Kouso

6

1 reference

26 December 2017

Tomoyoshi Takenaka

7

1 reference

26 December 2017

Naoko Miura

8

1 reference

26 December 2017

Hiroshi Okazaki

9

1 reference

26 December 2017

Yoshihiko Maehara

10

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

110

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

2793-2798

1 reference

26 December 2017

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

EGFR and cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Is there a role for CEA in innate immunity in the colon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

7 January 2021

Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

7 January 2021

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

7 January 2021

Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

7 January 2021

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23101

7 January 2021

Identifiers

DOI

10.1002/CNCR.23101

1 reference

26 December 2017

1 reference

26 December 2017